1173783

Nicholas K. Mollanazar, MD — FEI 3022635338

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 1, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Philadelphia, PA (United States)

Additional Details

Clinical Investigator (CI)